Boiron SA
PAR:BOI

Watchlist Manager
Boiron SA Logo
Boiron SA
PAR:BOI
Watchlist
Price: 29.6 EUR -2.63% Market Closed
Market Cap: 519.5m EUR

Relative Value

The Relative Value of one BOI stock under the Base Case scenario is hidden EUR. Compared to the current market price of 29.6 EUR, Boiron SA is hidden .

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

BOI Relative Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
77
vs Industry
72
Median 3Y
1.2
Median 5Y
1.3
Industry
2.6
Forward
1
vs History
11
vs Industry
27
Median 3Y
19.7
Median 5Y
19.7
Industry
21.4
Forward
12.4
vs History
82
vs Industry
38
Median 3Y
11.9
Median 5Y
11.9
Industry
16.4
vs History
77
vs Industry
20
Median 3Y
25.9
Median 5Y
25.9
Industry
22.8
vs History
42
vs Industry
58
Median 3Y
1.3
Median 5Y
1.3
Industry
2.2
vs History
55
vs Industry
78
Median 3Y
0.9
Median 5Y
0.9
Industry
2.9
Forward
0.8
vs History
53
vs Industry
83
Median 3Y
1.2
Median 5Y
1.3
Industry
5.5
vs History
50
vs Industry
41
Median 3Y
6.5
Median 5Y
6.4
Industry
13
Forward
5.5
vs History
23
vs Industry
32
Median 3Y
12.6
Median 5Y
11.7
Industry
16.5
Forward
9.4
vs History
60
vs Industry
41
Median 3Y
9.7
Median 5Y
9.7
Industry
15.6
vs History
61
vs Industry
27
Median 3Y
16.2
Median 5Y
16.2
Industry
18.7
vs History
49
vs Industry
65
Median 3Y
1
Median 5Y
1
Industry
1.9

Multiples Across Competitors

BOI Competitors Multiples
Boiron SA Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
FR
Boiron SA
PAR:BOI
503.2m EUR 1 26.5 6.3 16.6
US
Eli Lilly and Co
NYSE:LLY
1T USD 17.6 56.7 38 40.7
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
US
Johnson & Johnson
NYSE:JNJ
499.2B USD 5.4 19.9 16.3 21.1
CH
Roche Holding AG
SIX:ROG
267.7B CHF 4.3 28.4 12.1 14.1
UK
AstraZeneca PLC
LSE:AZN
220.3B GBP 5.1 31.6 108.8 159.2
US
Merck & Co Inc
NYSE:MRK
276B USD 4.3 14.5 10.3 12.2
CH
Novartis AG
SIX:NOVN
218.3B CHF 4.9 19.1 12.1 15.6
DK
Novo Nordisk A/S
CSE:NOVO B
1.6T DKK 5.1 15.6 10.9 12.6
IE
Endo International PLC
LSE:0Y5F
213.9B USD 92.2 -73.2 338.7 849.2
US
Pfizer Inc
NYSE:PFE
146.1B USD 2.3 14.9 7.6 10.3
P/E Multiple
Earnings Growth PEG
FR
Boiron SA
PAR:BOI
Average P/E: 25.2
26.5
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
56.7
54%
1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A N/A
US
Johnson & Johnson
NYSE:JNJ
19.9
29%
0.7
CH
Roche Holding AG
SIX:ROG
28.4
29%
1
UK
AstraZeneca PLC
LSE:AZN
31.6
37%
0.9
US
Merck & Co Inc
NYSE:MRK
14.5
15%
1
CH
Novartis AG
SIX:NOVN
19.1
17%
1.1
DK
Novo Nordisk A/S
CSE:NOVO B
15.6
3%
5.2
IE
E
Endo International PLC
LSE:0Y5F
Negative Multiple: -73.2 N/A N/A
US
Pfizer Inc
NYSE:PFE
14.9
27%
0.6
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
FR
Boiron SA
PAR:BOI
Average EV/EBITDA: 400.6
6.3
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
38
34%
1.1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
3 846.3
36%
106.8
US
Johnson & Johnson
NYSE:JNJ
16.3
9%
1.8
CH
Roche Holding AG
SIX:ROG
12.1
5%
2.4
UK
AstraZeneca PLC
LSE:AZN
108.8
10%
10.9
US
Merck & Co Inc
NYSE:MRK
10.3
6%
1.7
CH
Novartis AG
SIX:NOVN
12.1
6%
2
DK
Novo Nordisk A/S
CSE:NOVO B
10.9
1%
10.9
IE
E
Endo International PLC
LSE:0Y5F
338.7
N/A N/A
US
Pfizer Inc
NYSE:PFE
7.6
0%
N/A
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
FR
Boiron SA
PAR:BOI
Average EV/EBIT: 1 714
16.6
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
40.7
36%
1.1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
17 702.3
98%
180.6
US
Johnson & Johnson
NYSE:JNJ
21.1
15%
1.4
CH
Roche Holding AG
SIX:ROG
14.1
6%
2.4
UK
AstraZeneca PLC
LSE:AZN
159.2
23%
6.9
US
Merck & Co Inc
NYSE:MRK
12.2
8%
1.5
CH
Novartis AG
SIX:NOVN
15.6
12%
1.3
DK
Novo Nordisk A/S
CSE:NOVO B
12.6
0%
N/A
IE
E
Endo International PLC
LSE:0Y5F
849.2
N/A N/A
US
Pfizer Inc
NYSE:PFE
10.3
7%
1.5